News | June 04, 2008

MRI Procedure Growth Slowing to 3 Percent, Says Study

June 5, 2008 - According to IMV's recent census of MRI sites in the U.S., an estimated 27.5 million MRI procedures were performed at 7,195 sites in 2007, a 14 percent increase from 24.2 million in 2003, for an average annualized rate of 3 percent per year.

This represents a slowdown in procedure growth compared to the beginning of the decade, when the average annual growth rate from 1999 to 2003 was approximately 15 percent per year.

"Several factors are contributing to the slower growth of MRI procedures, which in turn influences MRI purchases," said Lorna Young, senior director, market research at IMV. "With the advent of the Deficit Reduction Act (DRA) of 2005, precertification requirements from health insurers, and the relative maturity of the MRI market, MRI purchases have slowed.

"Currently, virtually all of the hospitals above 200 beds have at least one MRI, and the DRA has slowed the acquisition of MRI systems by independent imaging centers. Unlike CT, which is used 24/7 for emergency and scheduled procedures, MRI procedures tend to be provided on a scheduled basis for specifically prescribed indications. We have also observed that the replacement cycle for MRI is getting longer, which is slowing the number of MRIs that are replaced.

"New procedures are the key avenue for growth, and 3T MRIs are providing some of the market excitement for the future. While only 3 percent of the units installed in 2003 were 3T, at least 20 percent of those who are planning to purchase MRI over the next few years are planning to purchase these systems as replacement or additional units for their department."

For more information: www.imvinfo.com

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...